Baxter Suspends Multiple-Dose Heparin Manufacturing Due To Excess Adverse Events

Firm avoids FDA recall; continues to manufacture single-dose vials of blood thinner.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet